Guggenheim Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
6,235
-819
| -12% | -$141K | 0.01% | 863 |
|
|
2025
Q1 | $1.1M | Sell |
7,054
-195
| -3% | -$30.4K | 0.01% | 844 |
|
|
2024
Q4 | $998K | Buy |
7,249
+5,218
| +257% | +$718K | 0.01% | 920 |
|
|
2024
Q3 | $303K | Buy |
2,031
+217
| +12% | +$32.4K | ﹤0.01% | 1609 |
|
|
2024
Q2 | $247K | Buy |
+1,814
| New | +$247K | ﹤0.01% | 1702 |
|
|
2022
Q4 | – | Sell |
-2,571
| Closed | -$265K | – | 1913 |
|
|
2022
Q3 | $265K | Buy |
+2,571
| New | +$265K | ﹤0.01% | 1702 |
|
|
2022
Q2 | – | Sell |
-2,008
| Closed | -$236K | – | 2048 |
|
|
2022
Q1 | $236K | Buy |
2,008
+135
| +7% | +$15.9K | ﹤0.01% | 1979 |
|
|
2021
Q4 | $252K | Buy |
1,873
+562
| +43% | +$75.6K | ﹤0.01% | 1949 |
|
|
2021
Q3 | $209K | Buy |
+1,311
| New | +$209K | ﹤0.01% | 2048 |
|